Mogamulizumab ( DrugBank: Mogamulizumab )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
26	HTLV-1関連脊髄症	3

26. HTLV-1関連脊髄症

臨床試験数 : 29 / 薬物数 : 47 - (DrugBank : 29) / 標的遺伝子数 : 34 - 標的パスウェイ数 : 119

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-JMA-IIA00324	29/06/2017	23/01/2018	A Phase 3 Study of KW-0761 (Mogamulizumab) in Subjects with HTLV-1 Associated Myelopathy (HAM)	A Phase 3 Multicenter, Randomized, Double-Blind and Placebo-Controlled Study, and Open Study of KW-0 ...	HTLV-1 associated Myelopathy (HAM)	Intervention type:DRUG. Intervention1:KW-0761, Dose form:INJECTION, Route of administration:INTRAVEN ...	Kyowa Kirin Co., Ltd	NULL	Completed	>=20 YEARS	No Limit	BOTH	52	Phase 3	Japan
2	JPRN-JapicCTI-173608	15/6/2017	06/06/2017	A Phase 3 Study of KW-0761 in Subjects with HTLV-1 Associated Myelopathy (HAM)	A Phase 3 Multicenter, Randomized, Double-Blind and Placebo-Controlled Study, and Open Study of KW-0 ...	HTLV-1 associated Myelopathy (HAM)	Intervention name : KW-0761 INN of the intervention : Mogamulizumab Dosage And administration of the i ...	Kyowa Kirin Co., Ltd.	NULL	complete	20		BOTH	52	Phase 3	Japan
3	JPRN-UMIN000016683	2015/03/13	05/03/2015	Novel autologous dendritic cell vaccine therapy targeting HTLV-1 specific antigen Combined with anti ...	Novel autologous dendritic cell vaccine therapy targeting HTLV-1 specific antigen Combined with anti ...	Adult T-cell leukemia/lymphoma	Tax-targeting DC vaccine KW-0761 (Mogamulizumab)	Japan Agency for Medical Research and Development	National Hospital Organization Kyushu Cancer Center	Complete: follow-up continuing	20years-old	75years-old	Male and Female	9	Phase 1	Japan

First Previous1Next Last